Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticles by Peasarrodona, Mireia et al.
This is an Accepted Manuscript, which has been through the  
Royal Society of Chemistry peer review process and has been 
accepted for publication.
Accepted Manuscripts are published online shortly after 
acceptance, before technical editing, formatting and proof reading. 
Using this free service, authors can make their results available 
to the community, in citable form, before we publish the edited 
article. We will replace this Accepted Manuscript with the edited 
and formatted Advance Article as soon as it is available.
You can find more information about Accepted Manuscripts in the 
author guidelines.
Please note that technical editing may introduce minor changes 
to the text and/or graphics, which may alter content. The journal’s 
standard Terms & Conditions and the ethical guidelines, outlined 
in our author and reviewer resource centre, still apply. In no 
event shall the Royal Society of Chemistry be held responsible 
for any errors or omissions in this Accepted Manuscript or any 
consequences arising from the use of any information it contains. 
Accepted Manuscript
rsc.li/nanoscale
Nanoscale
www.rsc.org/nanoscale
ISSN 2040-3364
PAPER
Qian Wang et al.
TiC2: a new two-dimensional sheet beyond MXenes
Volume 8 Number 1 7 January 2016 Pages 1–660
Nanoscale
View Article Online
View Journal
This article can be cited before page numbers have been issued, to do this please use:  M. Pesarrodona,
E. Crosas, R. Cubarsi, A. Sanchez-Chardi, P. Saccardo, U. Unzueta, F. Rueda, L. Sánchez-García, N. Serna,
R. Mangues, N. Ferrer-Miralles, E. Vazquez and A. Villaverde, Nanoscale, 2017, DOI:
10.1039/C6NR09182B.
Journal Name  
ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1  
Please do not adjust margins 
Please do not adjust margins 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
Intrinsic functional and architectonic heterogeneity of tumor-
targeted protein nanoparticles 
Mireia Pesarrodona a, b, c, Eva Crosas d, Rafael Cubarsi e, Alejandro Sánchez-Chardi f, Paolo Saccardo 
a, b, c, Ugutz Unzueta c, g, Fabian Rueda a, b, c, Laura Sanchez-García a, b, c, Naroa Serna a, b, c, Ramón 
Mangues c, g, Neus Ferrer-Miralles 1,2,3, Esther Vázquez a, b, c *, Antonio Villaverde a, b, c * 
 
Self-assembling proteins are gaining interest as building blocks of application-tailored nanoscale materials. This is mostly 
due to biocompatibility, biodegradability, and functional versatility of peptide chains. Such potential for adaptability is 
particularly high in the case of recombinant proteins, which produced in living cells are suited for genetic engineering. 
However, how the cell factory itself and the particular protein folding machinery influence architecture and function of the 
final material is still poorly explored. In this study we have used diverse analytic approaches, including small-angle X-ray 
scattering (SAXS) and field emission scanning electron microscopy (FESEM) to determine the fine architecture and 
geometry of recombinant, tumor-targeted protein nanoparticles of interest as drug carriers, constructed on a GFP-based 
modular scheme. A set of related oligomers were produced in alternative Escherichia coli strains with variant protein 
folding networks. This resulted into highly regular populations of morphometric types, ranging from 2.4 to 28 nm and from 
spherical to rod-shaped materials. These differential geometric species, whose relative proportions were determined by 
features of the producing strain, were found associated to particular fluorescence emission, cell penetrability and receptor 
specificity profiles. Then, nanoparticles with optimal properties could be analytically identified and further isolated from 
producing cells for use. The cell’s protein folding machinery greatly modulates the final geometry reached by the 
constructs, which in turn defines key parameters and biological performance of the material. 
Introduction   
The controlled self-assembling of synthetic peptides and 
recombinant proteins is a powerful tool in the generation of 
functional, micro and nanostructured materials. Recombinant 
proteins benefit, over synthetic peptides, from the versatility of 
biological fabrication. Based on a generic set of genetic 
engineering procedures, recombinant protein production has 
largely impacted on biotechnological and biopharmaceutical 
industries, with more than 400 protein drugs approved for 
human use [1]. The identification  [2, 3] and exploitation [4, 5] 
of oligomerization domains, the tailored fibrillation of amyloidal 
protein forms [6] and the de novo design of protein-protein 
interacting patches [7, 8] offer a wide spectrum of possibilities 
regarding the generation of supramolecular materials to be 
used in biological interfaces [9-11]. Being functional but also 
biocompatible and biodegradable, protein materials show a still 
unexplored biomedical potential in both regenerative medicine 
and conventional or cell-targeted drug delivery [12, 13]. The 
natural tendency of GFP to oligomerize [14] and the more 
recent manipulation of GFP assembling [15, 16] have attracted 
interest as this beta-sheet rich protein represents a compact, 
structurally stable building block for the assay of controlled 
oligomer formation and material characterization.  
In previous studies, we have developed a protein engineering 
platform to promote the self-assembly of modular GFP 
constructs, based on the combination of end-terminal cationic 
stretches and polyhistidines [17, 18]. Driven by electrostatic 
interactions and with a strong involvement of the histidine-rich 
tail, these peptides promote the formation of stable oligomers 
of defined average size in the nanoscale irrespective of the 
amino acid sequence and origin of the core protein placed in 
between. The resulting nanoparticles, with a toroid-like shape 
and usually ranging between 12 and 40 nm, are full stable in 
vivo [19]. Such stability under physiological conditions, provided 
by complex forces sustaining protein-protein cross-interactions,   
enable the material escaping from renal clearance and it also 
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allows prolonged circulation time in blood [19]. When 
displaying appropriate peptide ligands of cell surface cancer 
markers CXCR4 or CD44 (T22 and A5G27 respectively) they 
specifically accumulate in primary tumor and metastasis in 
colorectal and mammary cancer models respectively [20, 21], 
being suited for antitumoral drug delivery. The same platform 
has been used to construct fluorescent nanoparticles that cross 
the blood-brain barrier and target the brain [18].  
Recently [22], we have determined that self-assembled T22-
GFP-H6 oligomers elute from Immobilized Metal Affinity 
Chromatography (IMAC) in two separate fractions with slightly 
different sizes and CXCR4+ cell penetrability, suggesting 
alternative solvent exposure of both the His tag and the T22 
tumor homing peptide. Also, the bacterial species and strain 
used for production influence the size and biodistribution of the 
material upon systemic administration in animal models of 
CXCR4+ colorectal cancer [23, 24]. Altogether, these data 
indicate that bacterial cells can fabricate GFP-based 
nanoparticles of biomedical interest in alternative 
conformations. Such a possibility could be relevant to the in vivo 
use of these materials in a therapeutic context but in general, 
to the production of self-assembling protein materials with 
specialized functions. As this suspected architectonic deviation 
has been so far elusive, we have examined here the functional 
traits as well as the subunit organization of closely related, GFP-
based nanoparticles produced in alternative Escherichia coli 
strains, specially focusing to intrinsic functional and 
morphometric variability resulting from the biofabrication 
process. We demonstrate, for the first time, subtle size- and 
shape-dependent heterogeneity of protein nanoparticles linked 
to their functional properties, which determines the 
performance of the materials as intracellular, cell-targeted 
vehicles. The identified segregation allows the selection, by 
their geometry, of specific oligomer populations in which 
receptor-specificity and cancer cell uptake are dramatically 
improved. 
 
Experimental 
Protein production  
T22-GFP-H6 and A5G27-GFP-H6 are self-assembling modular 
proteins (Supplementary Figure 1) targeted to CXCR4 and CD44 
respectively, through amino terminal peptides (T22, 
RRWCYRKCYKGYCYRKCR and A5G27, RLVSYNGIIFFLK) binding 
these cell surface receptors [20, 21].  T22-GFP-H6 was produced 
in Escherichia coli Origami B [F−ompT hsdSB (rB− mB−) gal dcm 
lacY1 ahpC (DE3) gor522::Tn10 trxB (KanR, TetR)] (Novagen, 
Madison, WI, USA), encoded in a pET22b-derived vector, and in 
the endotoxin-free KPM335 (msbA52, ΔgutQ, ΔkdsD, ΔlpxL, 
ΔlpxM, ΔpagP, ΔlpxP, ΔeptA, frr181), its parental BW30270 
(CGSC#7925–MG1655; F−, rph+, fnr+) and the routine wild type 
MC4100 (F− [araD139]B/r, Del(argF-lac)169, flhD5301, Δ(fruK-
yeiR)725(fruA25), relA1, rpsL150(strR), rbsR22, Del(fimB-
fimE)632(::IS1), deoC1) from a pTrc99a-derivative plasmid. 
A5G27-GFP-H6 and the control GFP-H6 protein with an N-
terminal random (non-cationic) peptide were produced in E. coli 
BL21 DE3 (Novagen, Madison, WI, USA) transformed with 
pET22b and pET21b plasmids respectively. All encoding gene 
sequences were optimised for expression according to the E. 
coli codon usage. Protein production was induced by the 
addition of 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
to in bacterial cultures that were further cultivated overnight at 
20 ºC in LB medium with the selective antibiotic (at 16 ºC for 
A5G27-GFP-H6 producing cultures).  
 
Protein purification  
Proteins were purified as previously described [20]. Briefly, cell 
pellets were resuspended in Wash Buffer (10 mM TrisHCl, 500 
mM NaCl, 10 mM Imidazol pH 8.0 in presence of protease 
inhibitors. Cell disruption was performed at 1,200 psi using a 
French Press and lysate was centrifuged at 15,000 g for 45 min. 
Protein was purified through the His-tag by Immobilized Metal 
Affinity Chromatography (IMAC) and protein separation was 
achieved using an Imidazole gradient up to 500 mM. Protein 
peak fractions were collected, dialysed against carbonate buffer 
(166 mM NaCO3H pH 7.4) and centrifuged to remove insoluble 
aggregates. Protein integrity was analysed by SDS 
electrophoresis on TGX Stain-Free gels (Bio-Rad, Hercules,CA, 
USA) and followed by Western blotting using an anti-His 
monoclonal antibody (Santa Cruz Biotechnology, Inc., 
Heidelberg, Germany). Protein concentration was determined 
by an adapted Bradford’s assay [25]. Proteins are found as 
nanoparticles upon purification, and no specific assembling 
protocols were applied. Oligomers are presumably formed 
already in the producing bacteria. 
 
Gel filtration 
Protein oligomers were analysed using Size-exclusion 
chromatography. Samples were loaded on a Superdex 200 
Increase 10/300 (GE Healthcare, Piscataway, NJ, USA) column 
pre-equilibrated with carbonate buffer at 0.75 ml/min. Protein 
samples intended for small-angle X-ray scattering (SAXS) were 
prepared by collecting fractions corresponding to each oligomer 
population and concentrated to 5 mg/ml, using Amicon 
Centrifugal Filters 3K (Millipore, Cork, Ireland). The supernatant 
was centrifuged at 15,000 g for 30 min to remove possible 
aggregates and stored at -80ºC. Protein oligomers were re-
analysed using the same SEC conditions to assess the structural 
stability upon separation. The hydrodynamic radius (Rh) was 
obtained using a protein standard (GE Healthcare, Piscataway, 
NJ, USA), and the relative amounts of oligomeric forms were 
calculated by Gaussian deconvolution of the obtained size-
exclusion chromatograms using the Peakfit 4.12 software 
(Systat Software Inc.) and applying a residual method to resolve 
the overlapped peaks. 
 
Dynamic light scattering (DLS) and fluorescence 
determination 
The volume size distribution of nanoparticles was determined 
at 1 mg/ml in carbonate buffer by dynamic light scattering at 
633 nm (Zetasizer Nano ZS, Malvern Instruments Limited, 
Malvern, UK). Green fluorescence was determined by a Varian 
Cary Eclipse fluorescence spectrophotometer (Agilent 
Technologies, Santa Clara, CA, USA) at detection wavelength of 
510 nm and at 1 mg/ml protein concentration, by using an 
excitation wavelength of 450 nm. 
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Cell lines and protein internalization 
MDA-MB-231 cell line was maintained in RPMI 1640 
supplemented with 10 % fetal bovine serum (FBS) and 6 mM 
GlutaMAX (Invitrogen, Carlsbad, CA, USA), whereas HeLa (ATCC-
CCL-2) cells were maintained in MEMα (GIBCO, Rockville, MD, 
USA) supplemented with 10 % FBS. Both cell lines were 
incubated at 37 ºC and 5 % CO2. To analyse protein 
internalization, HeLa and MDA-MB-231 were cultured on 24-
well plates at 3·104 cells/well and 8·104 cells/well respectively 
until reaching 70 % confluence. The medium was discarded and 
the cells were washed twice with PBS (Sigma-Aldrich, 
Steinheim, Germany). Cells were then incubated with 
OptiPRO™ serum-free medium supplemented with L-glutamine 
with recombinant proteins dissolved at convenient 
concentrations for 3 h (T22-GFP-H6) or 24 h (A5G27-GFP-H6). 
AMD3100, a specific CXCR4 antagonist, was added to the cells 
at 10 mM, 1 h before protein addition, to assess the specificity 
of protein internalization. In parallel, to study protein 
endosomal escape, 50 mM chloroquine was added 3 h before 
protein addition. After protein incubation, the medium was 
removed and cells were washed with PBS. Cells were treated 
with 1 mg/ml trypsin for 15 min to remove protein bound to cell 
surface followed by the addition of complete medium. Then 
they were centrifuged at 1,200 rpm for 15 min and the pellet 
was resuspended in PBS. Protein internalization was analysed 
using a FACS-Canto system (Becton Dickinson, Franklin Lakes, 
NJ, USA) using a 15 mW air-cooled argon ion laser at 488 nm 
excitation. Experiments were performed in duplicate. 
 
SAXS measurements 
SAXS profiles were recorded in the Non-Crystalline Diffraction 
(NCD) beamline at ALBA Synchrotron Light Source (Cerdanyola 
del Vallès, Barcelona, Spain), by using an imXPAD-S1400 
photon-counting detector (ImXPAD, La Ciotat, France) placed at 
5.9 m from the sample. Multiple frames of 0.5-2 seconds 
exposure time were collected at 12.4 keV energy (λ = 1 Å) 
without attenuation. Samples were measured in a Teflon cell 
with a path length of 3 mm and mica windows of 25 µm 
thickness. SAXS data were processed by using the EMBL-
Hamburg ATSAS software package [26]. The radius of gyration, 
Rg, was calculated from the pair-distances distribution function 
by using GNOM [27]. Prior to Rg calculation, similarity between 
frames was assessed using the Correlation Map (CorMap) test 
[28] in order to discard frames with radiation damage. The 
fitting of the scattering profiles after background subtraction to 
the different form factors was performed by using SasView 
3.1.2. The ratio between the radius of gyration Rg determined 
by SAXS and the hydrodynamic radius Rh determined by SEC, 
Rg/Rh, was used as an estimator of the geometry of the different 
nanoparticles. 
 
Electron Microscopy 
The near native state ultrastructure of NP was assessed with 
Field Emission Scanning Electron Microscopy (FESEM) and 
Transmission Electron Microscopy (TEM). For FESEM, drops of 3 
µl of P1 samples (Origami B and KPM335 IMAC fraction 2), P2 
(Origami B and KPM335 IMAC fraction 2), P4 (KPM335 IMAC 
fraction 1 and 2), and P5 (Origami B and KPM335 IMAC fraction 
2) were directly deposited on a silicon surface (Ted Pella Inc., 
Reading, CA, USA) for 1 min, air dried and observed without 
coating in a FESEM Merlin (Zeiss, Oberkochen, Germany) 
operating at 2 kV. Images were acquired with a high resolution 
in-lens secondary electron detector. For TEM, drops of 3 µl from 
the same 8 samples, at the same concentrations used for 
FESEM, were deposited for 2 min on 400 mesh carbon coated 
copper grids, contrasted with 2 % uranyl acetate for 2 min, air 
dried and observed with a transmission electron microscope 
JeolJEM-1400 (Jeol Ltd., Tokyo, Japan) operating at 80 kV. 
Images were acquired with a CCD Gatan ES1000W Erlangshen 
camera (Gatan, Abingdon, UK).  
Length and width of 325 nanoparticles from P1 samples (ASG27, 
Origami B and KPM335 IMAC fraction 1 and 2), P2 (ASG27, 
Origami B and KPM335 IMAC fraction 2), P3 (KPM335 IMAC 
fraction 1), P4 (KPM335 IMAC fraction 1 and 2), and P5 (ASG27, 
Origami B and KPM335 IMAC fraction 1 and 2) were quantified 
from TEM images using DigitalMicrograph software (Gatan, 
Abingdon, UK). 
 
Data analysis 
Values are expressed as mean data and standard error 
calculated using Microsoft Excel 2003. Pairwise divergences 
were detected through Student t-tests using Microsoft Excel 
2003. Significant differences were assumed at p<0.05. Graphical 
representations were obtained using Sigmaplot 10.0 software. 
 
Mathematical methods 
Internalization I and Receptor-dependent internalization R are 
variables found depending on the specific fluorescence F and 
SEC elution volume E. According to Rueda and co-workers [22], 
the relationship I(F) is given by ln(I) = a + bF. The receptor-
dependent specific internalization R(F) is also approximately 
linear R = p + qF. To interpret the plots of I(E) and R(E) shown in 
Fig. 5B it was previously necessary to analize the relationship 
between the specific Fluorescence F and the SEC-Elution 
volume E plotted in Figure 5 A, which presents two main 
features: first, the symmetry about the maximum specific 
fluorescence F(e0) (green line); second, the linear and opposite 
trends of the dots about this symmetry point. To find out the 
value e0, the data were approximated by a parabola (in grey), by 
providing the optimal SEC elution volume point at e0 =14.4 ml. 
Now it was possible to calculate the least squares 
approximation for the following relationship (blue lines), 
F = m + n|E − e0| 
Therefore, the compositions of functions I(F(E)) and R(F(E)) 
necessarily show the same behaviour represented in Figure 5 B. 
The symmetry point e0 matches the previous value. The 
regression curve in blue of Fig. 3B was 
ln(I) = a′ + b′|E − e0|; a′ = a + bm; b′ = bn 
and the curve in red was 
R = p′ + q′|E − e0|; p′ = p + qm; q′ = qn 
The particular role of the optimal SEC elution volume e0 was also 
noticeable in terms of other parameters, such as the 
hydrodynamic diameter and the form. 
 
 
Page 3 of 8 Nanoscale
N
an
os
ca
le
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
10
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t A
ut
on
om
a 
de
 B
ar
ce
lo
na
 o
n 
18
/0
4/
20
17
 1
0:
56
:1
7.
 
View Article Online
DOI: 10.1039/C6NR09182B
ARTICLE Journal Name 
4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
Results and discussion 
The de novo designed A5G27-GFP-H6 and T22-GFP-H6 
nanoparticles show, by dynamic light scattering (DLS), average 
size peaks of 14 and 12 nm respectively when produced in the 
conventional E. coli strains BL21 (DE3) and Origami B 
respectively [19, 20] (Supplementary Figure 1). Any intrinsic 
morphometric heterogeneity, if existing, has been so far 
unobserved and eclipsed in the analysis of the raw material. 
However, when T22-GFP-H6 is purified from bacterial cell 
extracts by IMAC, it is eluted in two separated fractions [22], a 
fact that indicates alternative solvent exposures of the 
histidine-rich terminal tail. In this context, and to examine in 
detail the potential intrinsic heterogeneity in the architecture of 
these materials, we have screened by SEC the intra-strain size 
spectrum of T22-GFP-H6 nanoparticles occurring in these two 
separate IMAC fractions, upon production in different E. coli 
strains. 
 
 
Figure 1. Morphometric variability of T22-GFP-H6. A. SEC 
chromatograms of T22-GFP-H6 protein produced in KPM335, BW30270 
or MC4100 and present on fraction 1 (left, low affinity) or fraction 2 
(right, high affinity) of IMAC purification.  Black lines indicate the 
average plot of the elution process. Numbers represent the percentage 
of protein amount in each oligomer population (only for nanoparticles 
represented over 5 %), and line colours indicate regularly appearing 
peaks. Most representative oligomeric populations produced in 
KPM335 strain are identified as P1-P5 for further evaluation. A SEC 
calibration curve is depicted in the Supplementary Figure 2. B. Summary 
of size and fluorescence emission of major populations of GFP variants. 
Coloured numbers indicate the protein populations, segregated by size 
and shape in SEC, as indicted in A.  
We included in the analysis the endotoxin-free E. coli strain 
KPM335, that is particularly interesting not only because of its 
interest in biomedicine as an endotoxin-free cell factory [29] but 
also because of the complex genetic modifications performed 
to remove endotoxic components from the cell wall. Such 
manipulation has resulted in the constitutive up or down 
regulation of several heat-shock genes involved in the quality 
control of recombinant proteins [23]. As observed (Figure 1 A), 
the resulting nanoparticles were distributed in numerous peaks, 
contrasting with the apparent morphometric homogeneity 
determined by DLS over the pooled material (Supplementary 
Figure 1). The sizes of nanoparticle populations were highly 
coincident when comparing bacterial strains, and even when 
comparing IMAC fractions 1 and 2, indicative of high regularity 
in the oligomerization states of GFP. In this regard, the 
differences observed were mostly lying on the relative 
proportions of these populations. For instance, T22-GFP-H6 
oligomers from IMAC fraction 1 accumulated in SEC peaks P3 
and P5, while the material present in the IMAC fraction 2 tended 
to majorly occur in SEC peaks P1 and P2. P5 appeared to 
correspond to the unassembled protein forms, namely the 
monomeric or probably dimeric building blocks. Both the 
proteolytic stability of the modular proteins and the structural 
stability of the oligomers were fully confirmed by SDS-PAGE on 
TGX Stain-Free gel (Supplementary Figure 3 A) and by a SEC re-
analysis of selected SEC fractions (Supplementary Figure 3 B) 
respectively. 
Size (DLS and SAXS) and specific fluorescence (fluorimetry) of 
the relevant protein populations separated by SEC were 
determined by independent techniques (Figure 1 B), in an 
exhaustive analysis that also included A5G27-GFP-H6 from E. 
coli BL21 and T22-GFP-H6 produced in Origami B (both eluted in 
a single IMAC fraction). Again, a high coincidence with size data 
and elution peaks was observed, here also extended to inter 
protein pairwise comparisons. The unassembled P5 forms of 
GFP-H6, A5G27-GFP-H6 and T22-GFP-H6 usually ranged 
between 2 and 3 nm of radius, P4, when observed, around 4 
nm, P3 around 5 nm, P2 between 6 and 7 nm and P1 between 
11 and 13 nm. Nanoparticle and oligomer size were finally 
determined by TEM imaging of isolated materials 
(Supplementary Table 1), resulting in values again in good 
agreement with more indirect analytical data (Figure 1 B). The 
size coincidence when comparing all those analytical 
approaches confirmed the robustness in the assembling pattern 
of the GFP oligomers, which appeared to be highly regular 
despite the nature of the cationic peptide at the amino terminus 
of the construct.  Just a few data among those obtained were 
out of these ranges. In particular, T22-GFP-H6 nanoparticles 
from the IMAC elution fraction 1 of KPM335 showed an unusual 
high comparative size, which is coincident with previous 
observations [22], indicative of a differential organization of the 
fully assembled building blocks. Interestingly, all protein 
fractions were fluorescent, but higher emission values were 
generically observed in the monomeric forms (P5) when 
comparing fully assembled nanoparticles and intermediate 
oligomers (P1 and P2, 50 % of less fluorescent than the building 
Page 4 of 8Nanoscale
N
an
os
ca
le
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
10
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t A
ut
on
om
a 
de
 B
ar
ce
lo
na
 o
n 
18
/0
4/
20
17
 1
0:
56
:1
7.
 
View Article Online
DOI: 10.1039/C6NR09182B
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5  
Please do not adjust margins 
Please do not adjust margins 
blocks). The range of fluorescence emission independently 
confirmed alternative conformational status of the 
oligomerized GFP. All these data allowed proposing, in 
summary, a variable organization of GFP oligomers probably 
due to alternative protein-protein contact patterns that might 
be favoured in particular producing strains. 
The different architectonic patterns adopted by GFP oligomers 
would necessarily be connected to distinct morphometries and 
biophysical properties of the materials, which have been so far 
generically identified as planar, toroid nanoparticles [19]. In this 
context, fine SAXS analyses revealed a broad range of shapes, 
from rod forms to spherical forms, depending on the SEC 
population to which they belong (Figure 2 A). Also, the 
molecular flexibility of the overhanging peptides from GFP-
fusions was also variable (Figure 2 B), revealing a changeable 
potential of the building block to adopt alternative 
conformations that might limit, impair or favour specific 
oligomeric organizations. The best fitting of the SAXS profiles for 
the materials to different form factors was determined by using 
SasView, as shown in the Supplementary Figure 4. The 
alternative morphometries in SEC peaks identified by SAXS were 
fully assessed by high resolution TEM and FESEM imaging 
(Figure 3), confirming the nano-architectonic variability of 
nanoparticles in a fully visual way.  
 
Figure 2. Shape and flexibility of GFP-based oligomers. A. Nanoparticle 
shape based on the Rg/Rh ratio. Larger oligomers show an oblate 
ellipsoid shape in comparison with the prolate/stiff rod shape exhibited 
by monomers. B. Normalized Kratky plot from the scattering curve of 
T22-GFP-H6 KPM335 IMAC fraction2 oligomeric organizations. The peak 
position corresponding to a globular protein, which has a value of 
qRg=√3 with a maximum at 1.104, is indicated with grey-dashed lines as 
a reference. Nanoparticle compactness is directly proportional with 
size. Higher nanoparticles display a curve representative of compact 
structures whereas smaller nanoparticles show peptide flexibility. 
The protein nanoparticles studied here had been conceived as 
drug carriers for cancer treatments, what was lately encouraged 
by their good biodistribution when systemically administrated 
(upon which the material accumulated intracellularly in tumor 
and metastatic foci but not in liver, kidney, spleen or other non-
target organs) [19, 20]. Then, how the morphometry and other 
physical properties of the oligomeric populations might 
influence receptor-dependent cell penetration is a critical issue 
that was addressed in a CXCR4+ cell culture model. As observed 
(Figure 4 A), the unassembled populations of CXCR4-targeted 
nanoparticles were inefficient in penetrating target cells, 
although their uptake was clearly over the background values of 
the non-targeted, parental GFP-H6 (devoid of any receptor 
ligand). Noteworthy, cell penetrability was progressively gained 
with the complexity of the oligomers, indicating that the mere 
presence of a cell ligand is not sufficient to support 
internalisation. This was fully in agreement with previous data 
obtained with assembled and disassembled IRPF-based protein 
nanoparticles [30] and with the role of multivalence in the cell 
binding process and further receptor-mediated internalisation 
[12]. In fact, monovalent building blocks are equally inefficient 
in reaching their target in vivo [19].  
Although internalisation is significantly lower for discreet 
populations compared to larger structures, noticeably, the 
prevalence of peptide flexibility in P4 and P5 populations shown 
by the Normalized Kratky Plot (Figure 2 B) could also be involved 
in a favoured exposure of T22 to CXCR4 receptor, leading to 
major specific internalization. Note also that curves from 
populations P4 and P5 (Figure 2B) decay at higher qRg values, 
which is indicative of domain flexibility. Interestingly, T22-GFP-
H6 nanoparticles produced in KPM335 and present in the IMAC 
fraction 1, were all poorly internalized (in agreement with 
previous observations using the material pool, [22]), and 
showed also lower specificity. In these populations, both H6 and 
T22 tags might be both less available for intermolecular 
interactions, also fitting with the low affinity in IMAC. Surface 
charge of oligomers from the tested SEC peaks did not appear 
as a major factor in influencing protein cell interactions as it 
ranged within a narrow frame from -13.1 mV ± 0.6 to -11.1 mV 
± 0.3 (differences not significant, p> 0.07 in a T test; not shown). 
Therefore, despite the influence that ligand conformation or 
exposure might have on cell uptake, particle size was found as 
the major determinant of cell penetrability into target cells, as 
larger oligomers, presenting enhanced multivalency, internalize 
more efficiently (compare to P4 and P5) (Figure 4 A and B). 
Further internalization analysis with A5G27-GFP-H6 protein 
oligomers in presence of chloroquine showed an increase in 
protein lysosomal degradation with a decrease on oligomer size 
(Figure 4 B). Endosomal escape of larger oligomers was then 
more efficient compared to smaller protein assembles and 
together with the entrance specificity suggest an unspecific 
internalization route alternative to clathrin-mediated 
endocytosis pathway for P1 populations, which do not lead to 
late endosome avoiding subsequent protein degradation [31]. 
In this regard, the impact that nanoparticle geometry (size and 
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shape) has on cell penetrability [32] and biodistribution [33] has 
been demonstrated. However, the influence of these 
parameters may vary depending of bulk material [34] and, so 
far, the effect on protein-based nanoparticles have not been 
closely examined. In receptor-targeted nanoparticles that are 
activated with overhanging peptides, uptake might be in 
addition modulated by the exposure and bioavailability of 
functional ligands on the particle’s surface. In our system, these 
ligands are the tumor homing peptides A5G27 and T22, while 
the H6 tail has an important role in the endosomal escape upon 
internalization [35].  
 
Figure 3. Morphometry at ultrastructural level of GFP oligomers. 
Representative TEM and FESEM images of T22-GFP-H6 oligomers 
produced in the E. coli strains Origami B and KPM335, classified by their 
occurrence in SEC peaks. Bar sizes represent 20 nm in general views and 
10 nm in detail images. Shapes within the panels correspond to the 
expected particle form and their colours to the peak in the plots from 
Figure 1. 
The variability in the specific GFP fluorescence emission when 
comparing all the nanoparticles studied here (Figure 1 B) 
suggested alternative configurations of the material [22]. In this 
context, and for a global analysis of the potential relationships 
between physical and biological properties of the variant 
oligomers, we performed a numerical screening of 
dependences between both sets of parameters. Interestingly, 
highly fluorescent protein particles were regularly collected in 
the elution SEC peaks around 14 ml, (Figure 5 A), formed by a 
population of nanoparticles that exhibit medium size. These 
materials are not particularly efficient as potential drug 
vehicles, since although receptor dependent penetrability 
shows a maximum value here, the cell penetrability (amount of 
internalized material) is contrarily low (Figure 5 B). Interestingly, 
GFP oligomers eluted at this stage (around 14 ml in the SEC 
elution volume, corresponding to the SEC P4), represent a 
functional and morphometric inflexion in the continuum of 
forms of the assembled protein. In this regard, the SEC P4 
sample represents a virtual frontier between two set of 
nanoparticles, regarding the variability of the morphometric 
traits of the whole protein population (Figure 5 B). Among the 
morphometric population spectrum derived from the cell 
factory, it is possible to identify and separate by SEC the 
supramolecular organisation of the nanoparticles that display 
optimal biological properties. In this regard, for this particular 
system, oligomers from P2 population (which adopt a spherical 
shape) exhibit higher cell internalisation and better receptor 
specificity (Figure 5 B), probably because of a combination of 
solvent exposure of T22, optimal size and appropriate 
multivalence of the ligand for cell surface interactions.  
In summary, protein nanoparticles generated through the 
combination of a cationic, cell targeting peptide at the amino 
terminus of a core GFP and a histidine rich domain at the C-
terminus exhibit a spectrum of oligomerization forms previously 
eclipsed by the pooled analysis of the material (Figure 1 A). The 
major oligomeric states of the nanoparticles are coincident 
when comparing proteins constructed with unrelated amino-
terminal tags such as A5G27 and T22, and targeted to different 
cell surface receptors (CD44 and CXCR4, respectively), revealing 
very regular patterns in the oligomerization process. 
 
Figure 4. Cell internalization of protein oligomers. A. Internalization in 
HeLa cells of T22-GFP-H6 oligomers produced in Origami B and KPM 335 
strains, determined by the intracellular fluorescence, upon corrected by 
specific fluorescence (values are then representative of protein 
amounts). Numbers on top refer to the inhibition of protein entrance 
by means of a specific CXCR4 antagonist, AMD3100, and indicate the 
specificity of the internalization process. B. Internalization in MDA-MB-
231 cells of A5G27-GFP-H6 oligomers. Numbers refer to the 
percentages of protein that escape from endosomal degradation (* for 
p<0.05) which is also indicated by the grey bars.  
These variants exhibit distinguishable biophysical properties 
including shape, size, fluorescence emission, cellular 
penetrability and receptor-dependent specificity, some of them 
critical when considering the applicability of these protein 
materials as drug carriers in systemic treatments. Interestingly, 
and considering that high molecular mass of building blocks in 
protein-only materials are exclusively produced by biological 
fabrication, the genetic background of the producing cell is 
dramatically influencing these abilities. Note for instance the 
poor penetrability of all nanoparticles produced in KPM335 
released in the IMAC fraction 1 contrarily to the same material 
released in fraction 2 (Figure 4). This is probably due to the 
impact that altered protein folding machineries have in the 
Page 6 of 8Nanoscale
N
an
os
ca
le
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
10
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t A
ut
on
om
a 
de
 B
ar
ce
lo
na
 o
n 
18
/0
4/
20
17
 1
0:
56
:1
7.
 
View Article Online
DOI: 10.1039/C6NR09182B
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 7  
Please do not adjust margins 
Please do not adjust margins 
conformation of the building block, what might be amplified 
upon assembly as complex oligomeric species.  
 
Figure 5. Relationships between relevant parameters of T22-GFP-H6 
nanoparticle populations. A. Regression lines for specific fluorescence 
F(E) (blue), quadratic prediction F(E) (grey), and symmetry point (green). 
B. Regression curves for protein internalization (logarithm) I(E) 
(blue)and receptor-dependent cell internalization R(E) (red) in terms of 
the SEC-elution volume. Quadratic predictions in grey and symmetry 
point in green. 
At the present stage of understanding of the protein quality 
control, it is not possible to rationally predict the assembling 
pattern and functional profile of a protein nanoparticle when 
produced in a defined bacterial strain. However, since the yield 
of building block production in bacteria is relatively high (11-23 
mg/l of culture, before any media and process optimization; not 
shown), it would be possible to separate, at the downstream 
stage, particularly convenient material fractions for high 
performance biological application, and then discard the less 
efficient. For the materials explored here, proteins eluted in SEC 
between 8 and 10 ml would appropriately combine high 
penetrability with high receptor specificity (Figure 5 B), what is 
not the general case as these parameters tend to evolve in 
divergent fashions. Also, this set of materials show high particle 
sizes (Figure 1B) and geometries ranging from spheres to 
discoidal (oblate spheres) versions, far from the more 
elongated, poorly penetrating versions (Figure 2 A and 4 A). This 
is again stressing the regular shaped, high multimerization 
forms as the most efficient architectonic patterns for receptor-
mediated cell penetration. 
 
Conclusions 
Comparing with other types of nanostructures, protein-only 
nanoparticles are fully compatible with biological systems, 
providing a suitable platform for biomedical uses such as drug 
delivery and imaging probes. Far than chemical composition, 
size and shape are crucial factors determining the relationships 
between nanoparticles and increasingly complex biological 
systems (namely from cells to entire organisms) in critical 
aspects such as organ specificity and biodistribution [36-40], 
toxicity [41], and cell uptake and fate [39, 42-45]. Although 
previously checked in several types of nanostructures, mainly in 
crystalline nano- and micromaterials, the present study is the 
first evaluation of form (geometry) and function (cellular 
uptake) of protein nanoparticle populations. This has been done 
using a particular protein oligomerization platform that results 
in materials highly stable in vivo, what makes possible their 
applicability as vehicles for cell-targeted delivery of drugs and 
imaging agents. Although variability in the biofabrication of self-
assembling proteins might represent a priori a generic concern 
for reproducibility in in vivo applications, the high regularity and 
robustness of the oligomerization patterns instead allows the 
proper downstream selection of advantageous variants 
regarding a particular set of applications, such as cell 
penetrability and specificity in the receptor-dependent uptake 
of tumor-targeted protein nanoparticles.  
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